130 related articles for article (PubMed ID: 2821104)
1. Specificity of increased des-gamma-carboxyprothrombin in hepatocellular carcinoma after vitamin K1 injection.
Lefrère JJ; Gozin D; Soulier JP; Bettan L; Mavier P; Dhumeaux D; Guillaumont M; Leclercq M
J Hepatol; 1987 Aug; 5(1):27-9. PubMed ID: 2821104
[TBL] [Abstract][Full Text] [Related]
2. Des-gamma-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review.
Weitz IC; Liebman HA
Hepatology; 1993 Oct; 18(4):990-7. PubMed ID: 8406374
[TBL] [Abstract][Full Text] [Related]
3. Des-gamma-carboxyprothrombin in hepatocellular carcinoma after vitamin K1 injection.
Buffet C; Bismuth E; Hagege H; Etienne JP
Dig Dis Sci; 1989 Jun; 34(6):963-4. PubMed ID: 2470560
[No Abstract] [Full Text] [Related]
4. Plasma abnormal prothrombin (des-gamma-carboxy prothrombin) as a marker of hepatocellular carcinoma.
Fujiyama S; Morishita T; Hashiguchi O; Sato T
Cancer; 1988 Apr; 61(8):1621-8. PubMed ID: 2450634
[TBL] [Abstract][Full Text] [Related]
5. Levels of vitamin K, immunoreactive prothrombin, des-gamma-carboxy prothrombin and gamma-glutamyl carboxylase activity in hepatocellular carcinoma tissue.
Yamagata H; Nakanishi T; Furukawa M; Okuda H; Obata H
J Gastroenterol Hepatol; 1995; 10(1):8-13. PubMed ID: 7620113
[TBL] [Abstract][Full Text] [Related]
6. Changes of plasma des-gamma-carboxy prothrombin levels in patients with hepatocellular carcinoma in response to vitamin K.
Furukawa M; Nakanishi T; Okuda H; Ishida S; Obata H
Cancer; 1992 Jan; 69(1):31-8. PubMed ID: 1309308
[TBL] [Abstract][Full Text] [Related]
7. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
Soga K; Watanabe T; Aikawa K; Toshima M; Shibasaki K; Aoyagi Y
Hepatogastroenterology; 1998; 45(23):1737-41. PubMed ID: 9840138
[TBL] [Abstract][Full Text] [Related]
8. A new method to assay des-gamma-carboxyprothrombin. Results obtained in 75 cases of hepatocellular carcinoma.
Soulier JP; Gozin D; Lefrere JJ
Gastroenterology; 1986 Nov; 91(5):1258-62. PubMed ID: 3019818
[TBL] [Abstract][Full Text] [Related]
9. Coagulation assays as diagnostic markers of hepatocellular carcinoma.
Lefrère JJ; Conard J; Mavier P; Bettan L; Beaugrand M; Gozin D; Lerable J; Dhumeaux D; Samama M
Thromb Haemost; 1988 Dec; 60(3):468-70. PubMed ID: 2467402
[TBL] [Abstract][Full Text] [Related]
10. [Assay of decarboxy-prothrombin: its value in the diagnosis of hepatocellular carcinoma].
Soulier JP; Lefrère JJ; Gozin D
Ann Med Interne (Paris); 1988; 139(1):7-11. PubMed ID: 2834988
[TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of des-gamma-carboxy prothrombin assay in early diagnosis of hepatocellular carcinoma.
Fujiyama S; Izuno K; Gohshi K; Shibata J; Sato T
Dig Dis Sci; 1991 Dec; 36(12):1787-92. PubMed ID: 1721019
[TBL] [Abstract][Full Text] [Related]
12. The usefulness of determining des-gamma-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma.
Mita Y; Aoyagi Y; Yanagi M; Suda T; Suzuki Y; Asakura H
Cancer; 1998 May; 82(9):1643-8. PubMed ID: 9576283
[TBL] [Abstract][Full Text] [Related]
13. Serum des-gamma-carboxyprothrombin concentration determined by the avidin-biotin complex method in small hepatocellular carcinomas.
Saitoh S; Ikeda K; Koida I; Tsubota A; Arase Y; Chayama K; Kumada H
Cancer; 1994 Dec; 74(11):2918-23. PubMed ID: 7525036
[TBL] [Abstract][Full Text] [Related]
14. Abnormal prothrombin (DES-gamma-carboxy prothrombin) in hepatocellular carcinoma.
Nakao A; Virji A; Iwaki Y; Carr B; Iwatsuki S; Starzl E
Hepatogastroenterology; 1991 Oct; 38(5):450-3. PubMed ID: 1722483
[TBL] [Abstract][Full Text] [Related]
15. A study about mechanisms of des-gamma-carboxy prothrombin's production in hepatocellular carcinoma.
Bertino G; Ardiri AM; Boemi PM; Ierna D; Interlandi D; Caruso L; Minona E; Trovato MA; Vicari S; Li Destri G; Puleo S
Panminerva Med; 2008 Sep; 50(3):221-6. PubMed ID: 18927526
[TBL] [Abstract][Full Text] [Related]
16. Novel des-γ-carboxy prothrombin in serum for the diagnosis of hepatocellular carcinoma.
Tanaka T; Taniguchi T; Sannomiya K; Takenaka H; Tomonari T; Okamoto K; Kitamura S; Okahisa T; Tamaki K; Mikasa H; Suzuki S; Takayama T
J Gastroenterol Hepatol; 2013 Aug; 28(8):1348-55. PubMed ID: 23432345
[TBL] [Abstract][Full Text] [Related]
17. Vitamin K2 inhibits the growth of hepatocellular carcinoma via decrease of des-gamma-carboxy prothrombin.
Ma M; Qu XJ; Mu GY; Chen MH; Cheng YN; Kokudo N; Tang W; Cui SX
Chemotherapy; 2009; 55(1):28-35. PubMed ID: 18974646
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and diagnostic value of des-γ-carboxy prothrombin in liver cancer.
Bertino G; Ardiri AM; Calvagno GS; Bertino N; Boemi PM
Drug News Perspect; 2010 Oct; 23(8):498-508. PubMed ID: 21031166
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic value of the assay of des-gamma-carboxy prothrombin in the detection of small hepatocellular carcinoma.
Chan CY; Lee SD; Wu JC; Lin HC; Huang YS; Lo GH; Lee FY; Tsai YT; Lo KJ
J Hepatol; 1991 Jul; 13(1):21-4. PubMed ID: 1717542
[TBL] [Abstract][Full Text] [Related]
20. Impairment of clathrin-mediated endocytosis via cytoskeletal change by epithelial to fibroblastoid conversion in HepG2 cells: a possible mechanism of des-gamma-carboxy prothrombin production in hepatocellular carcinoma.
Murata K; Sakamoto A
Int J Oncol; 2008 Dec; 33(6):1149-55. PubMed ID: 19020747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
